Regional chemotherapy for inoperable renal carcinoma: a method of targeting therapeutic microspheres to tumour.
Regionally-administered, drug-loaded microspheres have a potential role in the treatment of renal tumours. Vasoactive agents, for example, angiotensin II, may allow selective delivery of microspheres to tumour. The present study defines the regional advantage that may be obtained from angiotensin II by quantifying tumour and normal kidney blood flow using radiolabelled microsphere renal perfusion studies and per-operative laser-doppler flow measurements. Angiotensin II increased microsphere distribution to tumour, relative to normal kidney, by a factor of four. This enhancement was associated with an absolute increase in tumour blood flow.
Anderson
J H
JH
Department of Surgery, Royal Infirmary, Glasgow.
Willmott
N
N
Bessent
R
R
Angerson
W J
WJ
Kerr
D J
DJ
McArdle
C S
CS
D000804:Angiotensin II / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007261:Infusions, Intra-Arterial; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008863:Microspheres; D008875:Middle Aged
D000804:Angiotensin II